Navigation Links
Pfenex Inc. Launches reagentproteins.com
Date:11/2/2010

SAN DIEGO, Nov. 2, 2010 /PRNewswire/ -- Pfenex Inc. today announced the launch of a new business division, Reagent Proteins. Reagent Proteins will enhance the development scientists' ability to source complex reagent grade proteins at a competitive price.

Reagent Proteins will initially offer a product list in excess of 2300 proteins, including stem cell growth factors, cytokines, chemokines, and enzymes. A unique aspect of Reagent Proteins' offering includes vaccine carriers, adjuvants and antigens, available in both pre-clinical and cGMP quality grades. Reagent Proteins is the only protein supplier supporting human vaccine developers from discovery to commercialization with a broad range of vaccine components.

"As we continue to leverage our business based on efficient complex protein production, the Reagent Proteins business unit is an obvious choice," stated Bertrand C. Liang, Chief Executive Officer, "We have and continue to build a portfolio of proteins in areas of need, including those based upon monitoring of industry trends as well as direct feedback from the researchers themselves."

About Reagent Proteins

Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high quality proteins to enable their development efforts to proceed efficiently. www.reagentproteins.com

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Adaptive TCR Launches the immunoSEQâ„¢ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
2. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
3. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
4. CoreLab Partners Launches New DXA Imaging Service Offerings
5. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
6. InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
7. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
8. HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums
9. Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
10. Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
11. West Michigan Launches $10 Million Early Stage Venture Fund to Support Life Science & Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... BERG, a biopharmaceutical company uncovering health ... announced the appointment of Jason Haddock ... Haddock brings to BERG over 20 years of ... senior financial functions at pharmaceutical companies, as well ... Niven R. Narain , BERG,s ...
(Date:2/8/2016)... , Feb. 8, 2016  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced that it ... agreement with Hercules Technology Growth Capital, Inc. and ... million in financing. --> ... $25 million of financing under the loan and ...
(Date:2/8/2016)... Feb. 8, 2016  BioElectronics Corporation (OTC Pink: ... announced today that it is responding to a ... the Securities and Exchange Commission posted on the ... Chairman of the Board of BioElectronics Corporation and ... Administration at The Fuqua School of Business, Duke ...
(Date:2/8/2016)... Conn. , Feb. 8, 2016  NanoViricides, Inc. (NYSE MKT: ... its CEO, Eugene Seymour , MD, MPH, will present information ... at the Waldorf-Astoria Hotel in New York City ... will be in the Windsor Room at 5:30PM EST. Registered attendees ... New York City . --> ...
Breaking Biology Technology:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
Breaking Biology News(10 mins):